Late-stage reshaping of phage-displayed libraries to macrocyclic and bicyclic landscapes using multipurpose linchpin

31 January 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Genetically-encoded libraries (GEL) are increasingly used for discovery of ligands for ‘undruggable’ targets that cannot be addressed with small molecules. However, there is currently no consensus whether ‘zero knowledge’ naïve libraries or libraries with pre-existing knowledge can offer a more effective path to discover molecular interactions. In this manuscript, we evaluated the feasibility of discovery of macrocyclic and bicyclic peptide from "non-zero knowledge" libraries. Foundational GEL platforms like phage-, yeast-, ribosome- and mRNA-display originally enabled display of libraries composed of 20 natural amino acids (20AA). Today, numerous strategies expand GEL beyond 20AA space. Upgrading libraries by incorporating unnatural amino acids (UAA) and chemical post-translational modification (cPTM) can build linear, cyclic, and bicyclic peptides that would not be achievable for 20AA-GEL. The standard operating procedure for UAA and cPTM libraries starts from a "naïve" library with 108-1012 compounds, uses target of interest and rounds of selection to narrow down to a set of receptor binding hits. However, such approach uses zero knowledge of natural peptide-receptor interactions which already exists in libraries with 20AA space. We approach this problem by late-stage chemical reshaping of phage-displayed landscape of 20AA binders to NS3aH1 protease. The re-shaping is performed under a novel multifunctional C2-symmetric linchpin, 3,5-bis(bromomethyl)benzaldehyde (termed KYL), that combines two electrophiles that react with thiols and aldehyde group that reacts with N-terminal amine. KYL diversified phage-displayed peptides into bicyclic architectures and delineates 2 distinct sequence populations which was further validated by BLI: (i) retained binding upon bicyclization (ii) lost binding once chemically modified. Our report provides a case study for discovering advanced, chemically-upgraded macrocycles and bicycles from libraries with pre-existing knowledge. The results imply that thousands of selection campaigns completed in 20AA space, in principle, can serve for late-stage reshaping and as a starting point for discovery of advanced peptide-derived ligands.

Keywords

phage display
linchpin
NS3a
macrocycles
bicycle
peptide

Supplementary materials

Title
Description
Actions
Title
SupplementaryInformation
Description
Detailed synthetic methods, biochemical methods describing the synthesis and selection of phage libraries, biolayer interferometry assay, data processing methods describing the analysis of the DNA sequencing data, statistical methods
Actions
Title
Appendix2
Description
Detailed NMR spectra of KYL modified SAKGGRCYEDC macrocycles, purification methods, and characterizations of peptide macrocycles
Actions
Title
Supplementarydata
Description
(i) "Kinetics Matlab" directory with raw data used to monitor the kinetics of reactions and MatLab scripts for curve fit, (ii) " panning_sequencing_data" directory with *.txt files describing the raw deep-sequencing data; *.csv tables describing sequencing data after re-organization; *.xlsx tables describing sequencing data sorted in different libraries; *.pdf files describing the differential enrichment (DE) analysis, output of differential enrichment analysis and clustering; Cleaning_deep_seq_data.ipynb as Python script used for sequencing data processing. (iii) “MALDI” directory with MatLab scripts for MALDI data processing and raw MALDI data. (iv) “BLI” directory with raw BLI data and subtracted BLI data files
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.